Levi J Yant

Author PubWeight™ 26.45^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Reversion of CTL escape-variant immunodeficiency viruses in vivo.	Nat Med	2004	6.33
2	Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239.	J Virol	2006	4.68
3	Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication.	J Virol	2007	3.85
4	Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response.	J Virol	2004	2.71
5	Repression of flowering by the miR172 target SMZ.	PLoS Biol	2009	1.99
6	Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates.	J Virol	2004	1.79
7	Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay.	J Virol	2005	1.50
8	Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.	J Virol	2008	1.39
9	Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes.	J Virol	2006	1.22
10	Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts.	J Virol	2004	1.17